1 Report Overview 1.1 Study Scope 1.2 Market Analysis by Type 1.2.1 Global Depressive Disorder Market Size Growth Rate by Type: 2020 VS 2026 1.2.2 Tricyclic Antidepressants 1.2.3 Selective Serotonin Reuptake Inhibitors 1.2.4 Serotonin-Norepinephrine Reuptake Inhibitors 1.2.5 Monoamine Oxidase Inhibitors 1.2.6 Serotonin Antagonist And Reuptake Inhibitors 1.2.7 Others 1.3 Market by Application 1.3.1 Global Depressive Disorder Market Share by Application: 2020 VS 2026 1.3.2 Hospitals 1.3.3 Ambulatory Surgical Centers 1.3.4 Diagnostic Centers 1.3.5 Homecare Settings 1.3.6 Long Term Care Centers 1.4 Study Objectives 1.5 Years Considered 2 Global Growth Trends 2.1 Global Depressive Disorder Market Perspective (2015-2026) 2.2 Global Depressive Disorder Growth Trends by Regions 2.2.1 Depressive Disorder Market Size by Regions: 2015 VS 2020 VS 2026 2.2.2 Depressive Disorder Historic Market Share by Regions (2015-2020) 2.2.3 Depressive Disorder Forecasted Market Size by Regions (2021-2026) 2.3 Industry Trends and Growth Strategy 2.3.1 Market Trends 2.3.2 Market Drivers 2.3.3 Market Challenges 2.3.4 Market Restraints 3 Competition Landscape by Key Players 3.1 Global Top Depressive Disorder Players by Market Size 3.1.1 Global Top Depressive Disorder Players by Revenue (2015-2020) 3.1.2 Global Depressive Disorder Revenue Market Share by Players (2015-2020) 3.2 Global Depressive Disorder Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 3.3 Players Covered: Ranking by Depressive Disorder Revenue 3.4 Global Depressive Disorder Market Concentration Ratio 3.4.1 Global Depressive Disorder Market Concentration Ratio (CR5 and HHI) 3.4.2 Global Top 10 and Top 5 Companies by Depressive Disorder Revenue in 2019 3.5 Key Players Depressive Disorder Area Served 3.6 Key Players Depressive Disorder Product Solution and Service 3.7 Date of Enter into Depressive Disorder Market 3.8 Mergers & Acquisitions, Expansion Plans 4 Depressive Disorder Breakdown Data by Type (2015-2026) 4.1 Global Depressive Disorder Historic Market Size by Type (2015-2020) 4.2 Global Depressive Disorder Forecasted Market Size by Type (2021-2026) 5 Depressive Disorder Breakdown Data by Application (2015-2026) 5.1 Global Depressive Disorder Historic Market Size by Application (2015-2020) 5.2 Global Depressive Disorder Forecasted Market Size by Application (2021-2026) 6 North America 6.1 North America Depressive Disorder Market Size (2015-2026) 6.2 North America Depressive Disorder Market Size by Type (2015-2020) 6.3 North America Depressive Disorder Market Size by Application (2015-2020) 6.4 North America Depressive Disorder Market Size by Country (2015-2020) 6.4.1 United States 6.4.2 Canada 7 Europe 7.1 Europe Depressive Disorder Market Size (2015-2026) 7.2 Europe Depressive Disorder Market Size by Type (2015-2020) 7.3 Europe Depressive Disorder Market Size by Application (2015-2020) 7.4 Europe Depressive Disorder Market Size by Country (2015-2020) 7.4.1 Germany 7.4.2 France 7.4.3 U.K. 7.4.4 Italy 7.4.5 Russia 7.4.6 Nordic 7.4.7 Rest of Europe 8 China 8.1 China Depressive Disorder Market Size (2015-2026) 8.2 China Depressive Disorder Market Size by Type (2015-2020) 8.3 China Depressive Disorder Market Size by Application (2015-2020) 8.4 China Depressive Disorder Market Size by Region (2015-2020) 8.4.1 China 8.4.2 Japan 8.4.3 South Korea 8.4.4 Southeast Asia 8.4.5 India 8.4.6 Australia 8.4.7 Rest of Asia-Pacific 9 Japan 9.1 Japan Depressive Disorder Market Size (2015-2026) 9.2 Japan Depressive Disorder Market Size by Type (2015-2020) 9.3 Japan Depressive Disorder Market Size by Application (2015-2020) 9.4 Japan Depressive Disorder Market Size by Country (2015-2020) 9.4.1 Mexico 9.4.2 Brazil 10 Southeast Asia 10.1 Southeast Asia Depressive Disorder Market Size (2015-2026) 10.2 Southeast Asia Depressive Disorder Market Size by Type (2015-2020) 10.3 Southeast Asia Depressive Disorder Market Size by Application (2015-2020) 10.4 Southeast Asia Depressive Disorder Market Size by Country (2015-2020) 10.4.1 Turkey 10.4.2 Saudi Arabia 10.4.3 UAE 10.4.4 Rest of Middle East & Africa 11 Key Players Profiles 11.1 Alkermes 11.1.1 Alkermes Company Details 11.1.2 Alkermes Business Overview 11.1.3 Alkermes Depressive Disorder Introduction 11.1.4 Alkermes Revenue in Depressive Disorder Business (2015-2020)) 11.1.5 Alkermes Recent Development 11.2 Allergan 11.2.1 Allergan Company Details 11.2.2 Allergan Business Overview 11.2.3 Allergan Depressive Disorder Introduction 11.2.4 Allergan Revenue in Depressive Disorder Business (2015-2020) 11.2.5 Allergan Recent Development 11.3 Bristol Myers Squibb 11.3.1 Bristol Myers Squibb Company Details 11.3.2 Bristol Myers Squibb Business Overview 11.3.3 Bristol Myers Squibb Depressive Disorder Introduction 11.3.4 Bristol Myers Squibb Revenue in Depressive Disorder Business (2015-2020) 11.3.5 Bristol Myers Squibb Recent Development 11.4 Eli Lilly 11.4.1 Eli Lilly Company Details 11.4.2 Eli Lilly Business Overview 11.4.3 Eli Lilly Depressive Disorder Introduction 11.4.4 Eli Lilly Revenue in Depressive Disorder Business (2015-2020) 11.4.5 Eli Lilly Recent Development 11.5 Glaxosmithkline 11.5.1 Glaxosmithkline Company Details 11.5.2 Glaxosmithkline Business Overview 11.5.3 Glaxosmithkline Depressive Disorder Introduction 11.5.4 Glaxosmithkline Revenue in Depressive Disorder Business (2015-2020) 11.5.5 Glaxosmithkline Recent Development 11.6 H. Lundbeck 11.6.1 H. Lundbeck Company Details 11.6.2 H. Lundbeck Business Overview 11.6.3 H. Lundbeck Depressive Disorder Introduction 11.6.4 H. Lundbeck Revenue in Depressive Disorder Business (2015-2020) 11.6.5 H. Lundbeck Recent Development 11.7 Merck 11.7.1 Merck Company Details 11.7.2 Merck Business Overview 11.7.3 Merck Depressive Disorder Introduction 11.7.4 Merck Revenue in Depressive Disorder Business (2015-2020) 11.7.5 Merck Recent Development 11.8 Pfizer 11.8.1 Pfizer Company Details 11.8.2 Pfizer Business Overview 11.8.3 Pfizer Depressive Disorder Introduction 11.8.4 Pfizer Revenue in Depressive Disorder Business (2015-2020) 11.8.5 Pfizer Recent Development 11.9 Teva Pharmaceutical 11.9.1 Teva Pharmaceutical Company Details 11.9.2 Teva Pharmaceutical Business Overview 11.9.3 Teva Pharmaceutical Depressive Disorder Introduction 11.9.4 Teva Pharmaceutical Revenue in Depressive Disorder Business (2015-2020) 11.9.5 Teva Pharmaceutical Recent Development 11.10 Takeda Pharmaceutical 11.10.1 Takeda Pharmaceutical Company Details 11.10.2 Takeda Pharmaceutical Business Overview 11.10.3 Takeda Pharmaceutical Depressive Disorder Introduction 11.10.4 Takeda Pharmaceutical Revenue in Depressive Disorder Business (2015-2020) 11.10.5 Takeda Pharmaceutical Recent Development 12 Analyst's Viewpoints/Conclusions 13 Appendix 13.1 Research Methodology 13.1.1 Methodology/Research Approach 13.1.2 Data Source 13.2 Disclaimer 13.3 Author Details

List of Tables Table 1. Global Depressive Disorder Market Size Growth Rate by Type (US$ Million): 2020 VS 2026 Table 3. Key Players of Tricyclic Antidepressants Table 4. Key Players of Selective Serotonin Reuptake Inhibitors Table 5. Key Players of Serotonin-Norepinephrine Reuptake Inhibitors Table 6. Key Players of Monoamine Oxidase Inhibitors Table 7. Key Players of Serotonin Antagonist And Reuptake Inhibitors Table 8. Key Players of Others Table 9. Global Depressive Disorder Market Size Growth by Application (US$ Million): 2020 VS 2026 Table 10. Global Depressive Disorder Market Size by Regions (US$ Million): 2020 VS 2026 Table 11. Global Depressive Disorder Market Size by Regions (2015-2020) (US$ Million) Table 12. Global Depressive Disorder Market Share by Regions (2015-2020) Table 13. Global Depressive Disorder Forecasted Market Size by Regions (2021-2026) (US$ Million) Table 14. Global Depressive Disorder Market Share by Regions (2021-2026) Table 15. Depressive Disorder Market Market Trends Table 16. Depressive Disorder Market Drivers Table 17. Depressive Disorder Market Challenges Table 18. Depressive Disorder Market Restraints Table 19. Global Depressive Disorder Revenue by Players (2015-2020) (US$ Million) Table 20. Global Depressive Disorder Market Share by Players (2015-2020) Table 21. Global Top Depressive Disorder Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Depressive Disorder as of 2019) Table 22. Global Depressive Disorder by Players Market Concentration Ratio (CR5 and HHI) Table 23. Key Players Headquarters and Area Served Table 24. Key Players Depressive Disorder Product Solution and Service Table 25. Mergers & Acquisitions, Expansion Plans Table 26. Global Depressive Disorder Market Size by Type (2015-2020) (US$ Million) Table 27. Global Depressive Disorder Market Size Share by Type (2015-2020) Table 28. Global Depressive Disorder Revenue Market Share by Type (2021-2026) Table 29. Global Depressive Disorder Market Size Share by Application (2015-2020) Table 30. Global Depressive Disorder Market Size by Application (2015-2020) (US$ Million) Table 31. Global Depressive Disorder Market Size Share by Application (2021-2026) Table 32. North America Depressive Disorder Market Size by Type (2015-2020) (US$ Million) Table 33. North America Depressive Disorder Market Share by Type (2015-2020) Table 34. North America Depressive Disorder Market Size by Application (2015-2020) (US$ Million) Table 35. North America Depressive Disorder Market Share by Application (2015-2020) Table 36. North America Depressive Disorder Market Size by Country (US$ Million) (2015-2020) Table 37. North America Depressive Disorder Market Share by Country (2015-2020) Table 38. Europe Depressive Disorder Market Size by Type (2015-2020) (US$ Million) Table 39. Europe Depressive Disorder Market Share by Type (2015-2020) Table 40. Europe Depressive Disorder Market Size by Application (2015-2020) (US$ Million) Table 41. Europe Depressive Disorder Market Share by Application (2015-2020) Table 42. Europe Depressive Disorder Market Size by Country (US$ Million) (2015-2020) Table 43. Europe Depressive Disorder Market Share by Country (2015-2020) Table 44. China Depressive Disorder Market Size by Type (2015-2020) (US$ Million) Table 45. China Depressive Disorder Market Share by Type (2015-2020) Table 46. China Depressive Disorder Market Size by Application (2015-2020) (US$ Million) Table 47. China Depressive Disorder Market Share by Application (2015-2020) Table 48. China Depressive Disorder Market Size by Region (US$ Million) (2015-2020) Table 49. China Depressive Disorder Market Share by Region (2015-2020) Table 50. Japan Depressive Disorder Market Size by Type (2015-2020) (US$ Million) Table 51. Japan Depressive Disorder Market Share by Type (2015-2020) Table 52. Japan Depressive Disorder Market Size by Application (2015-2020) (US$ Million) Table 53. Japan Depressive Disorder Market Share by Application (2015-2020) Table 54. Japan Depressive Disorder Market Size by Country (US$ Million) (2015-2020) Table 55. Japan Depressive Disorder Market Share by Country (2015-2020) Table 56. Southeast Asia Depressive Disorder Market Size by Type (2015-2020) (US$ Million) Table 57. Southeast Asia Depressive Disorder Market Share by Type (2015-2020) Table 58. Southeast Asia Depressive Disorder Market Size by Application (2015-2020) (US$ Million) Table 59. Southeast Asia Depressive Disorder Market Share by Application (2015-2020) Table 60. Southeast Asia Depressive Disorder Market Size by Country (US$ Million) (2015-2020) Table 61. Southeast Asia Depressive Disorder Market Share by Country (2015-2020) Table 62. Alkermes Company Details Table 63. Alkermes Business Overview Table 64. Alkermes Product Table 65. Alkermes Revenue in Depressive Disorder Business (2015-2020) (US$ Million) Table 66. Alkermes Recent Development Table 67. Allergan Company Details Table 68. Allergan Business Overview Table 69. Allergan Product Table 70. Allergan Revenue in Depressive Disorder Business (2015-2020) (US$ Million) Table 71. Allergan Recent Development Table 72. Bristol Myers Squibb Company Details Table 73. Bristol Myers Squibb Business Overview Table 74. Bristol Myers Squibb Product Table 75. Bristol Myers Squibb Revenue in Depressive Disorder Business (2015-2020) (US$ Million) Table 76. Bristol Myers Squibb Recent Development Table 77. Eli Lilly Company Details Table 78. Eli Lilly Business Overview Table 79. Eli Lilly Product Table 80. Eli Lilly Revenue in Depressive Disorder Business (2015-2020) (US$ Million) Table 81. Eli Lilly Recent Development Table 82. Glaxosmithkline Company Details Table 83. Glaxosmithkline Business Overview Table 84. Glaxosmithkline Product Table 85. Glaxosmithkline Revenue in Depressive Disorder Business (2015-2020) (US$ Million) Table 86. Glaxosmithkline Recent Development Table 87. H. Lundbeck Company Details Table 88. H. Lundbeck Business Overview Table 89. H. Lundbeck Product Table 90. H. Lundbeck Revenue in Depressive Disorder Business (2015-2020) (US$ Million) Table 91. H. Lundbeck Recent Development Table 92. Merck Company Details Table 93. Merck Business Overview Table 94. Merck Product Table 95. Merck Revenue in Depressive Disorder Business (2015-2020) (US$ Million) Table 96. Merck Recent Development Table 97. Pfizer Business Overview Table 98. Pfizer Product Table 99. Pfizer Company Details Table 100. Pfizer Revenue in Depressive Disorder Business (2015-2020) (US$ Million) Table 101. Pfizer Recent Development Table 102. Teva Pharmaceutical Company Details Table 103. Teva Pharmaceutical Business Overview Table 104. Teva Pharmaceutical Product Table 105. Teva Pharmaceutical Revenue in Depressive Disorder Business (2015-2020) (US$ Million) Table 106. Teva Pharmaceutical Recent Development Table 107. Takeda Pharmaceutical Company Details Table 108. Takeda Pharmaceutical Business Overview Table 109. Takeda Pharmaceutical Product Table 110. Takeda Pharmaceutical Revenue in Depressive Disorder Business (2015-2020) (US$ Million) Table 111. Takeda Pharmaceutical Recent Development Table 112. Research Programs/Design for This Report Table 113. Key Data Information from Secondary Sources Table 114. Key Data Information from Primary Sources List of Figures Figure 1. Global Depressive Disorder Market Share by Type: 2020 VS 2026 Figure 2. Tricyclic Antidepressants Features Figure 3. Selective Serotonin Reuptake Inhibitors Features Figure 4. Serotonin-Norepinephrine Reuptake Inhibitors Features Figure 5. Monoamine Oxidase Inhibitors Features Figure 6. Serotonin Antagonist And Reuptake Inhibitors Features Figure 7. Others Features Figure 8. Global Depressive Disorder Market Share by Application: 2020 VS 2026 Figure 9. Hospitals Case Studies Figure 10. Ambulatory Surgical Centers Case Studies Figure 11. Diagnostic Centers Case Studies Figure 12. Homecare Settings Case Studies Figure 13. Long Term Care Centers Case Studies Figure 14. Depressive Disorder Report Years Considered Figure 15. Global Depressive Disorder Market Size (US$ Million), YoY Growth 2015-2026 Figure 16. Global Depressive Disorder Market Share by Regions: 2020 VS 2026 Figure 17. Global Depressive Disorder Market Share by Regions (2021-2026) Figure 18. Global Depressive Disorder Market Share by Players in 2019 Figure 19. Global Top Depressive Disorder Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Depressive Disorder as of 2019 Figure 20. The Top 10 and 5 Players Market Share by Depressive Disorder Revenue in 2019 Figure 21. North America Depressive Disorder Market Size YoY Growth (2015-2026) & (US$ Million) Figure 22. United States Depressive Disorder Market Size YoY Growth (2015-2026) & (US$ Million) Figure 23. Canada Depressive Disorder Market Size YoY Growth (2015-2026) & (US$ Million) Figure 24. Europe Depressive Disorder Market Size YoY Growth (2015-2026) & (US$ Million) Figure 25. Germany Depressive Disorder Market Size YoY Growth (2015-2026) & (US$ Million) Figure 26. France Depressive Disorder Market Size YoY Growth (2015-2026) & (US$ Million) Figure 27. U.K. Depressive Disorder Market Size YoY Growth (2015-2026) & (US$ Million) Figure 28. Italy Depressive Disorder Market Size YoY Growth (2015-2026) & (US$ Million) Figure 29. Russia Depressive Disorder Market Size YoY Growth (2015-2026) & (US$ Million) Figure 30. Nordic Depressive Disorder Market Size YoY Growth (2015-2026) & (US$ Million) Figure 31. Rest of Europe Depressive Disorder Market Size YoY Growth (2015-2026) & (US$ Million) Figure 32. Asia-Pacific Depressive Disorder Market Size YoY Growth (2015-2026) & (US$ Million) Figure 33. China Depressive Disorder Market Size YoY Growth (2015-2026) & (US$ Million) Figure 34. Japan Depressive Disorder Market Size YoY Growth (2015-2026) & (US$ Million) Figure 35. South Korea Depressive Disorder Market Size YoY Growth (2015-2026) & (US$ Million) Figure 36. Southeast Asia Depressive Disorder Market Size YoY Growth (2015-2026) & (US$ Million) Figure 37. India Depressive Disorder Market Size YoY Growth (2015-2026) & (US$ Million) Figure 38. Australia Depressive Disorder Market Size YoY Growth (2015-2026) & (US$ Million) Figure 39. Rest of Asia-Pacific Depressive Disorder Market Size YoY Growth (2015-2026) & (US$ Million) Figure 40. Latin America Depressive Disorder Market Size YoY Growth (2015-2026) & (US$ Million) Figure 41. Mexico Depressive Disorder Market Size YoY Growth (2015-2026) & (US$ Million) Figure 42. Brazil Depressive Disorder Market Size YoY Growth (2015-2026) & (US$ Million) Figure 43. Middle East & Africa Depressive Disorder Market Size YoY Growth (2015-2026) & (US$ Million) Figure 44. Turkey Depressive Disorder Market Size YoY Growth (2015-2026) & (US$ Million) Figure 45. Saudi Arabia Depressive Disorder Market Size YoY Growth (2015-2026) & (US$ Million) Figure 46. UAE Depressive Disorder Market Size YoY Growth (2015-2026) & (US$ Million) Figure 47. Rest of Middle East & Africa Depressive Disorder Market Size YoY Growth (2015-2026) & (US$ Million) Figure 48. Alkermes Revenue Growth Rate in Depressive Disorder Business (2015-2020) Figure 49. Allergan Revenue Growth Rate in Depressive Disorder Business (2015-2020) Figure 50. Bristol Myers Squibb Revenue Growth Rate in Depressive Disorder Business (2015-2020) Figure 51. Eli Lilly Revenue Growth Rate in Depressive Disorder Business (2015-2020) Figure 52. Glaxosmithkline Revenue Growth Rate in Depressive Disorder Business (2015-2020) Figure 53. H. Lundbeck Revenue Growth Rate in Depressive Disorder Business (2015-2020) Figure 54. Merck Revenue Growth Rate in Depressive Disorder Business (2015-2020) Figure 55. Pfizer Revenue Growth Rate in Depressive Disorder Business (2015-2020) Figure 56. Teva Pharmaceutical Revenue Growth Rate in Depressive Disorder Business (2015-2020) Figure 57. Takeda Pharmaceutical Revenue Growth Rate in Depressive Disorder Business (2015-2020) Figure 58. Bottom-up and Top-down Approaches for This Report Figure 59. Data Triangulation Figure 60. Key Executives Interviewed

Alkermes Allergan Bristol Myers Squibb Eli Lilly Glaxosmithkline H. Lundbeck Merck Pfizer Teva Pharmaceutical Takeda Pharmaceutical